V C Broudy

2.1k total citations
19 papers, 1.8k citations indexed

About

V C Broudy is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, V C Broudy has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Genetics and 5 papers in Immunology. Recurrent topics in V C Broudy's work include Platelet Disorders and Treatments (5 papers), Cell Adhesion Molecules Research (4 papers) and Mesenchymal stem cell research (3 papers). V C Broudy is often cited by papers focused on Platelet Disorders and Treatments (5 papers), Cell Adhesion Molecules Research (4 papers) and Mesenchymal stem cell research (3 papers). V C Broudy collaborates with scholars based in United States, South Africa and Germany. V C Broudy's co-authors include Kenneth Kaushansky, J W Adamson, John M. Harlan, N Lin, Gerald M. Segal, K. H. Sprugel, Angelika Grossmann, Catherine Lofton–Day, N. L. Fox and M J Jorgensen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

V C Broudy

19 papers receiving 1.7k citations

Peers

V C Broudy

HEMAT

IMMUN

GENET

ONCOL

N Lin United States

K Kaushansky United States

J Breton-Gorius France

DD Wagner United States

Véronique Latger‐Cannard France

Hideya Ohashi Japan

MA Moore United States

Scott T. Avecilla United States

JW Adamson United States

Matthias Riewald United States

N Lin United States

V C Broudy

1.5k ×1.4

HEMAT

576 ×1.0

IMMUN

488 ×1.5

GENET

507 ×1.6

280 ×1.3

ONCOL

Citations per year, relative to V C Broudy V C Broudy (= 1×) peers N Lin

Countries citing papers authored by V C Broudy

Since Specialization

Citations

This map shows the geographic impact of V C Broudy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V C Broudy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V C Broudy more than expected).

Fields of papers citing papers by V C Broudy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V C Broudy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V C Broudy. The network helps show where V C Broudy may publish in the future.

Co-authorship network of co-authors of V C Broudy

This figure shows the co-authorship network connecting the top 25 collaborators of V C Broudy. A scholar is included among the top collaborators of V C Broudy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V C Broudy. V C Broudy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Broudy, V C, et al.. (2012). Evaluation of the impact of HIV serostatus, tobacco smoking and CD4 counts on epidermoid anal cancer survival. International Journal of STD & AIDS. 23(2). 77–82. 17 indexed citations

Broudy, V C. (2003). AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine. 25(2). 52–60. 154 indexed citations

Huss, Ralf, Daesik Hong, C Beckham, et al.. (1996). Neutralization of stem cell factor in vitro and in vivo: dose-dependent inhibition of stromal cells and induction of granulocyte/monocyte differentiation. Annals of Hematology. 72(4). 253–259. 2 indexed citations

Kaushansky, Kenneth, et al.. (1996). Do the Preclinical Effects of Thrombopoietin Correlate with Its In Vitro Properties?. Stem Cells. 14(S1). 108–111. 2 indexed citations

Kaushansky, Kenneth, et al.. (1996). Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice.. PubMed. 24(2). 265–9. 136 indexed citations

Liesveld, Jane L., et al.. (1995). Effect of stem cell factor on myelopoiesis potential in human Dexter-type culture systems.. PubMed. 23(3). 202–9. 10 indexed citations

Kaushansky, Kenneth, V C Broudy, Angelika Grossmann, et al.. (1995). Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy.. Journal of Clinical Investigation. 96(3). 1683–1687. 209 indexed citations

Linenberger, Michael, et al.. (1995). Stem cell factor production by human marrow stromal fibroblasts.. PubMed. 23(10). 1104–14. 57 indexed citations

Kaushansky, Kenneth, V C Broudy, N Lin, et al.. (1995). Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.. Proceedings of the National Academy of Sciences. 92(8). 3234–3238. 276 indexed citations

10.

Sabath, Diana F., Jonathan G. Drachman, K Kaushansky, & V C Broudy. (1994). Development of a cell line dependent on MPL ligand for proliferation. 1. 325. 3 indexed citations

11.

Kaushansky, Kenneth, S G Shoemaker, V C Broudy, et al.. (1992). Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3.. Journal of Clinical Investigation. 90(5). 1879–1888. 28 indexed citations

12.

Emanuel, PD, et al.. (1992). Familial and congenital polycythemia in three unrelated families. Blood. 79(11). 3019–3030. 54 indexed citations

13.

Zsebo, K M, K A Smith, Cynthia Hartley, et al.. (1991). Biological characteristics of recombinant rat and human stem cell factor. Stem Cells. 9(S1). 194–203. 3 indexed citations

14.

Broudy, V C, Kenneth Kaushansky, S G Shoemaker, Bharat B. Aggarwal, & J W Adamson. (1990). Muramyl dipeptide induces production of hemopoietic growth factors in vivo by a mechanism independent of tumor necrosis factor.. The Journal of Immunology. 144(10). 3789–3794. 14 indexed citations

15.

Kaushansky, Kenneth, V C Broudy, John M. Harlan, & J W Adamson. (1988). Tumor necrosis factor-alpha and tumor necrosis factor-beta (lymphotoxin) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo.. The Journal of Immunology. 141(10). 3410–3415. 79 indexed citations

16.

Broudy, V C, N Lin, Joan C. Egrie, et al.. (1988). Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide.. Proceedings of the National Academy of Sciences. 85(17). 6513–6517. 96 indexed citations

17.

Broudy, V C, John M. Harlan, & J W Adamson. (1987). Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.. The Journal of Immunology. 138(12). 4298–4302. 70 indexed citations

18.

Broudy, V C, Kenneth Kaushansky, John M. Harlan, & J W Adamson. (1987). Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.. The Journal of Immunology. 139(2). 464–468. 225 indexed citations

19.

Broudy, V C, Kenneth Kaushansky, Gerald M. Segal, John M. Harlan, & J W Adamson. (1986). Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor.. Proceedings of the National Academy of Sciences. 83(19). 7467–7471. 324 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact